EUVIMEDEUVIMED entdecken
EvaluationsstudieKlinische StudieOpen Access · CC BY-NC 4.0

Evaluation of a second-generation intercostal extravascular implantable cardioverter defibrillator lead with a pectoral pulse generator for sensing, defibrillation, and anti-tachycardia pacing

Shephal K Doshi iD, Reinoud E Knops iD, Adrian Ebner, Michael Husby iD, Alan Marcovecchio iD, Rick Sanghera iD, Don Scheck, Martin C Burke iD

Europace · 2025

DOI: 10.1093/europace/euaf044 ↗

Kurz gefasst

Evaluationsstudie in der Zeitschrift Europace, 2025. Verfasst von Shephal K Doshi und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Electrophysiology, Pacific Heart Institute, Santa Monica, CA, USA. Hauptthemen laut MEDLINE: Cardiac Pacing, Artificial, Defibrillators, Implantable, Electric Countershock, Tachycardia, Ventricular. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: AtaCor Medical, Inc.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aims

Intercostal extravascular implantable cardioverter defibrillator (EV-ICD) leads may work better in contact with the pericardium thereby directing pacing and defibrillation energy towards excitable myocytes. We report 3-month safety and performance outcomes with a second-generation intercostal EV-ICD lead paired with standard, commercially available ICD pulse generators (PGs). Methods and results Subjects undergoing a transvenous ICD (TV-ICD) procedure received a concomitant intercostal EV-ICD lead system. The intercostal EV-ICD lead was connected sequentially to a PG in a left pectoral and then a left mid-axillary location. Extravascular ICD lead assessment included sensing and defibrillation of induced ventricular arrhythmias and pacing capture. The intercostal EV-ICD system was followed in a ‘recording-only’ mode and the control TV-ICD system in ‘therapy delivery’ mode to compare stored events. Devices were evaluated prior to hospital discharge, 2 weeks, 1 month, 2 months, and 3 months post-implant. Defibrillation testing was repeated prior to lead removal; 20/20 (100%) were successfully implanted (median implant time of 9 min). Two major lead complications were reported over a mean of 82 days: (i) lead movement and (ii) infection of both the TV-ICD and EV-ICD systems. Intraoperative pacing capture was achieved with the integrated bipolar configuration in 19 of 20 (95%) subjects. Pacing capture with the EV-ICD system was tolerated in all subjects, with over 90% feeling no pain after a 1-month recovery from the procedure. Induced VF episodes were sensed in all subjects and defibrillated successfully in 17 of 17 patients (100%) with a left mid-axillary PG and 19 of 20 patients (95%) with a left pectoral PG. Sensing and defibrillation were successful in 18 of 18 (100%) tested prior to lead removal.

Conclusion

In this pilot experience with a second-generation intercostal EV-ICD lead implantation, sensing and defibrillation of induced VF were successful when paired with a standard ICD PG from either a left mid-axillary or pectoral pocket. Clinical trial registration NCT number: NCT05791032; URL: https://clinicaltrials.gov/study/NCT05791032

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cardiac Pacing, ArtificialDefibrillators, ImplantableElectric CountershockTachycardia, VentricularAgedFemaleHumansMaleMiddle AgedElectrodes, ImplantedEquipment DesignTreatment Outcome

Stichwörter der Autor:innen

Anterior mediastinumDefibrillationExtravascularICDIntercostal

Autor:innen und Institutionen

  • Department of Electrophysiology, Pacific Heart Institute, Santa Monica, CA, USA.
  • Department of Clinical and Experimental Cardiology, Amsterdam UMC, Academic Medical Center, Meibergdreef 9, Amsterdam, The Netherlands.
  • Cardiovascular Department, Sanatorio Italiano, Asunción, Paraguay.
  • Research and Development Department, AtaCor Medical, Inc., 905 Calle Amenecer #360, San Clemente, CA 92673, USA.
  • Childers Electrocardiology Lab, CorVita Science Foundation, 1006 S Michigan Ave, Suite 500, Chicago, IL 60605, USA.

ORCID-Profile: Shephal K Doshi, Reinoud E Knops, Michael Husby, Alan Marcovecchio, Rick Sanghera, Martin C Burke

Förderung

  • AtaCor Medical, Inc

Zitieren

APA

Doshi, S. K., Knops, R. E., Ebner, A., Husby, M., Marcovecchio, A., Sanghera, R., Scheck, D., & Burke, M. C. (2025). Evaluation of a second-generation intercostal extravascular implantable cardioverter defibrillator lead with a pectoral pulse generator for sensing, defibrillation, and anti-tachycardia pacing. Europace. https://doi.org/10.1093/europace/euaf044

Vancouver

Doshi SK, Knops RE, Ebner A, Husby M, Marcovecchio A, Sanghera R, et al. Evaluation of a second-generation intercostal extravascular implantable cardioverter defibrillator lead with a pectoral pulse generator for sensing, defibrillation, and anti-tachycardia pacing. Europace. 2025. doi:10.1093/europace/euaf044

BibTeX
@article{Doshi2025,
  author = {Doshi, Shephal K and Knops, Reinoud E and Ebner, Adrian and Husby, Michael and Marcovecchio, Alan and Sanghera, Rick and Scheck, Don and Burke, Martin C},
  title = {Evaluation of a second-generation intercostal extravascular implantable cardioverter defibrillator lead with a pectoral pulse generator for sensing, defibrillation, and anti-tachycardia pacing},
  journal = {Europace},
  year = {2025},
  doi = {10.1093/europace/euaf044}
}
Kostenlos starten →